首页|期刊导航|中国癌症防治杂志|奥沙利铂耐药结直肠癌细胞脂质代谢重编程特征及差异代谢物筛选

奥沙利铂耐药结直肠癌细胞脂质代谢重编程特征及差异代谢物筛选OA

Lipid metabolic reprogramming and differential metabolite screening in oxaliplatin-resistant colorectal cancer cells

中文摘要英文摘要

目的 探讨奥沙利铂耐药人结直肠癌细胞株HCT116/L的脂质代谢重塑特征,筛选与耐药相关的差异脂质分子并分析其潜在生物学功能.方法 以HCT116亲本细胞株和奥沙利铂耐药株(HCT116/L)为细胞模型.采用CCK-8法检测细胞对奥沙利铂的敏感性并计算耐药指数;通过划痕愈合、Transwell侵袭实验、体外细胞克隆实验分别评估两组细胞的迁移、侵袭和增殖能力.应用超高效液相色谱-串联质谱(ultra performance liquid chromatography-andem mass spectrometry,UPLC-MS/MS)非靶向脂质组学技术检测两组细胞的脂质代谢谱,经数据预处理后筛选差异脂质分子,并利用京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)数据库进行通路富集分析.结果 HCT116/L细胞对奥沙利铂的耐药指数为9.8,划痕愈合率、穿膜细胞数和细胞克隆形成能力均显著高于亲本HCT116细胞(均P<0.001).脂质组学共鉴定出81种差异脂质分子,差异脂质主要富集于甘油磷脂代谢、癌症中的胆碱代谢及鞘脂信号通路.鞘脂代谢、坏死性凋亡通路的差异丰度得分绝对值最高,自噬、表皮生长因子受体酪氨酸激酶抑制剂耐药等耐药相关通路亦呈显著的方向性扰动.结论 结直肠癌奥沙利铂耐药伴随显著的脂质代谢重编程,甘油磷脂与鞘脂代谢异常及自噬通路活化可能参与耐药过程,其耐药相关差异脂质分子有望成为监测耐药的潜在生物标志物.

Objective To examine the characteristics of lipid metabolic reprogramming in oxaliplatin-resistant human colorectal cancer cell line HCT116/L,screen for differential lipid molecules associated with drug resistance,and evaluate their potential biological functions.Methods The parental HCT116 cell line and its oxaliplatin-resistant derivative,HCT116/L,were used as the cell models.Oxaliplatin sensitivity was assessed by CCK-8 assay,and the resistance index(RI)was calculated.Cell migration,invasion,and clonogenic capacity were assessed via scratch wound healing,Transwell invasion,and in vitro cell colony formation assays,respectively.Untargeted lipidomics based on ultra performance liquid chromatography-andem mass spectrometry(UPLC-MS/MS)was performed to profile the lipidomes of the two cell groups.Following data preprocessing,differential lipid molecules were identified.Pathway enrichment analysis was per-formed using the Kyoto Encyclopedia of Genes and Genomes(KEGG)database.Results The RI of HCT116/L cells for oxaliplatin was determined to be 9.8.The wound healing rate,number of invaded cells,and colony-forming ability of HCT116/L cells were significantly higher than those of parental HCT116 cells(all P<0.001).Lipidomic analysis identified a total of 81 differential lipid molecules,which were predominantly associated with glycerophospholipid metabolism,choline metabolism in cancer,and sphingolipid signaling path-way.The sphingolipid metabolism and necroptosis pathways showed the highest absolute differential abundance scores,while drug re-sistance-related pathways,including autophagy and EGFR tyrosine kinase inhibitor resistance,also exhibited significant directional per-turbations.Conclusions Oxaliplatin resistance in colorectal cancer is accompanied by significant lipid metabolic reprogramming.Ab-errant glycerophospholipid and sphingolipid metabolism,along with autophagy pathway activation,may contribute to drug resistance.The identified drug resistance-associated differential lipid molecules hold promise as potential biomarkers for resistance monitoring.

廉富伟;谢丽叶;吴雪菲;胡榜利;宁淑芳

530021 南宁 广西医科大学附属肿瘤医院精准医学中心530021 南宁 广西医科大学附属肿瘤医院精准医学中心530021 南宁 广西医科大学附属肿瘤医院实验研究部530021 南宁 广西医科大学附属肿瘤医院实验研究部530021 南宁 广西医科大学附属肿瘤医院精准医学中心

医药卫生

结直肠癌细胞奥沙利铂药物耐受性脂质代谢非靶向脂质组学

Colorectal cancer cellsOxaliplatinDrug toleranceLipid metabolismUntargeted lipidomics

《中国癌症防治杂志》 2026 (4)

445-454,10

国家自然科学基金地区科学基金项目(8216044682260580)广西自然科学基金面上项目(2025GXNSFAA0695802025GXNSFAA069082)广西医科大学青年基金项目(GXMUYSF202449)

10.27054/j.cnki.ISSN.1674-5671.2026.04.07

评论